NCT05717504

Brief Summary

The goal of this clinical trial is to compare the use of long-term vs. shorter-term heart monitoring to detect atrial fibrillation after stroke. Patients will be implanted with a loop recorder and will have study follow-up at 3-, 6- an 12-months after implantation. The investigators will evaluate 24 patients, between the 3 centers, in the same way the investigators plan to evaluate a larger number of participants (\>1000) in a future study. This will allow us to learn if such a study is possible, identify potential implementation challenges, and develop strategies to overcome those difficulties.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at P25-P50 for not_applicable stroke

Timeline
Completed

Started Nov 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 13, 2023

Completed
26 days until next milestone

First Posted

Study publicly available on registry

February 8, 2023

Completed
9 months until next milestone

Study Start

First participant enrolled

November 1, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2025

Completed
Last Updated

October 5, 2023

Status Verified

October 1, 2023

Enrollment Period

11 months

First QC Date

January 13, 2023

Last Update Submit

October 4, 2023

Conditions

Keywords

Implantable Loop RecorderAnticoagulantStrokeAtrial fibrillation

Outcome Measures

Primary Outcomes (1)

  • Number of patients enrolled at in 6 months

    Median and interquartile range recruitment rate. We will use this rate to estimate the number of sites and enrollment duration required for a larger RCT.

    6 months

Secondary Outcomes (9)

  • Screened, declined and dropouts.

    2 years

  • Number of clinical endpoint events per diagnostic arm

    2 years

  • Quality of life survey analysis

    2 years

  • AF timing of diagnosis

    2 years

  • AF burden (1)

    2 years

  • +4 more secondary outcomes

Study Arms (2)

Disclosure

ACTIVE COMPARATOR

Group A (disclosure arm): patients and physicians will be informed about all AF episodes identified on ILR lasting for ≥6 minutes.

Device: Implantable Loop RecorderOther: Quality of life survey

Non-Disclosure

ACTIVE COMPARATOR

Group B (non-disclosure arm): patients and physicians will be only informed about AF episodes identified on ILR lasting for ≥24h. This longer threshold is selected because of its association with increased risk of systemic embolism.

Device: Implantable Loop RecorderOther: Quality of life survey

Interventions

Patients will be implanted with a loop recorder. Patients will be given the choice of remove the loop recorder after the 12-months follow-up visit or at the end of its battery life (approximately 3 years)

DisclosureNon-Disclosure

A quality of life survey will be performed at the end of the follow-up period. The survey will be done over the phone or in person if the follow-up visit is in person.

DisclosureNon-Disclosure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- Adult patients with cortical or subcortical, cryptogenic or non-cryptogenic acute ischemic stroke

You may not qualify if:

  • AF on 24-h inpatient or Holter monitoring
  • Atrial or ventricular thrombus
  • Other major-risk cardioembolic sources (e.g., mechanical valve)
  • Other indications (e.g., venous thromboembolism) or contraindications for OACs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

StrokeAtrial Fibrillation

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesArrhythmias, CardiacHeart DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Luciano A Sposato, MD, MBA

    LHSC - Western University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 13, 2023

First Posted

February 8, 2023

Study Start

November 1, 2023

Primary Completion

October 1, 2024

Study Completion

February 1, 2025

Last Updated

October 5, 2023

Record last verified: 2023-10